METTL14 and breast carcinoma: Besides, Panneerdoss et al. found that in METTL14-silenced breast cancer cells, RhoA and PI3K-AKT signaling pathways were highly enriched, which are well-known to be mediators of cancer progression and angiogenesis [85].